Nifty
Sensex
:
:
24008.00
79454.47
-265.80 (-1.09%)
-880.34 (-1.10%)

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 506128 | NSE: Not Listed

144.85
06-Feb-2025
  • Open
  • High
  • Low
  • Previous Close
  •  146.00
  •  146.95
  •  140.00
  •  143.50
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  3220
  •  4.62
  •  193.50
  •  81.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 103.37
  • 9.54
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 167.69
  • N/A
  • 1.29

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 72.30%
  • 0.31%
  • 24.73%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 2.66%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.27
  • 14.64
  • 5.00

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.95
  • 29.67
  • 0.44

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.49
  • -
  • 5.22

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 11.93
  • 10.60
  • 11.11

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.26
  • 1.37
  • 1.68

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.16
  • 7.57
  • 6.77

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Net Sales
40.22
50.99
-21.12%
48.36
42.61
13.49%
50.12
48.74
2.83%
46.37
40.91
13.35%
Expenses
35.94
45.02
-20.17%
41.12
37.33
10.15%
41.50
42.25
-1.78%
40.57
36.17
12.16%
EBITDA
4.27
5.97
-28.48%
7.24
5.29
36.86%
8.62
6.50
32.62%
5.80
4.74
22.36%
EBIDTM
10.63%
11.71%
14.97%
12.40%
17.19%
13.33%
12.50%
11.58%
Other Income
0.19
0.10
90.00%
0.95
0.22
331.82%
0.11
0.24
-54.17%
0.25
0.27
-7.41%
Interest
1.23
1.35
-8.89%
1.39
1.43
-2.80%
1.50
1.16
29.31%
1.41
1.19
18.49%
Depreciation
1.79
1.78
0.56%
1.94
1.74
11.49%
1.83
1.60
14.38%
1.85
1.59
16.35%
PBT
1.45
2.94
-50.68%
4.87
2.34
108.12%
5.40
3.98
35.68%
2.79
2.23
25.11%
Tax
0.24
0.76
-68.42%
1.46
0.47
210.64%
1.42
0.65
118.46%
0.55
0.79
-30.38%
PAT
1.21
2.18
-44.50%
3.41
1.87
82.35%
3.99
3.33
19.82%
2.25
1.44
56.25%
PATM
3.02%
4.27%
7.06%
4.39%
7.95%
6.83%
4.84%
3.52%
EPS
1.05
1.89
-44.44%
2.97
1.63
82.21%
3.46
2.89
19.72%
1.95
1.25
56.00%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
185.07
188.71
167.61
163.03
90.06
95.31
108.78
105.50
94.81
71.18
102.75
Net Sales Growth
0.99%
12.59%
2.81%
81.02%
-5.51%
-12.38%
3.11%
11.28%
33.20%
-30.73%
 
Cost Of Goods Sold
93.49
102.81
88.82
89.64
41.76
45.28
52.71
54.90
49.94
37.80
66.91
Gross Profit
91.58
85.90
78.79
73.39
48.30
50.04
56.07
50.60
44.87
33.38
35.83
GP Margin
49.48%
45.52%
47.01%
45.02%
53.63%
52.50%
51.54%
47.96%
47.33%
46.90%
34.87%
Total Expenditure
159.13
165.17
144.62
140.00
80.11
88.89
98.56
95.76
82.41
61.21
90.73
Power & Fuel Cost
-
6.37
5.37
5.24
4.29
4.12
3.13
2.99
3.27
2.11
2.45
% Of Sales
-
3.38%
3.20%
3.21%
4.76%
4.32%
2.88%
2.83%
3.45%
2.96%
2.38%
Employee Cost
-
23.72
20.05
17.43
13.68
14.08
13.06
11.68
9.22
7.46
7.72
% Of Sales
-
12.57%
11.96%
10.69%
15.19%
14.77%
12.01%
11.07%
9.72%
10.48%
7.51%
Manufacturing Exp.
-
24.04
21.73
19.86
13.97
17.03
15.53
13.96
14.24
9.04
8.66
% Of Sales
-
12.74%
12.96%
12.18%
15.51%
17.87%
14.28%
13.23%
15.02%
12.70%
8.43%
General & Admin Exp.
-
6.48
6.32
5.06
4.69
5.80
5.99
6.29
4.36
3.27
2.82
% Of Sales
-
3.43%
3.77%
3.10%
5.21%
6.09%
5.51%
5.96%
4.60%
4.59%
2.74%
Selling & Distn. Exp.
-
1.72
2.00
2.20
1.36
1.38
6.80
4.20
0.98
0.95
1.34
% Of Sales
-
0.91%
1.19%
1.35%
1.51%
1.45%
6.25%
3.98%
1.03%
1.33%
1.30%
Miscellaneous Exp.
-
0.02
0.32
0.58
0.36
1.20
1.34
1.74
0.41
0.57
1.34
% Of Sales
-
0.01%
0.19%
0.36%
0.40%
1.26%
1.23%
1.65%
0.43%
0.80%
0.81%
EBITDA
25.93
23.54
22.99
23.03
9.95
6.42
10.22
9.74
12.40
9.97
12.02
EBITDA Margin
14.01%
12.47%
13.72%
14.13%
11.05%
6.74%
9.40%
9.23%
13.08%
14.01%
11.70%
Other Income
1.50
0.82
0.77
0.33
0.21
0.67
2.11
1.34
0.99
0.70
0.81
Interest
5.53
5.35
4.95
5.23
5.08
4.60
3.89
4.32
4.92
4.29
4.40
Depreciation
7.41
6.96
6.53
5.87
5.16
4.46
3.82
3.74
3.75
2.90
2.99
PBT
14.51
12.05
12.28
12.26
-0.08
-1.97
4.62
3.02
4.71
3.48
5.44
Tax
3.67
2.42
3.65
4.01
0.28
0.95
1.31
1.97
1.02
0.97
1.18
Tax Rate
25.29%
20.08%
29.72%
32.71%
-350.00%
-48.22%
28.35%
65.23%
21.66%
27.87%
21.69%
PAT
10.86
9.60
8.62
8.24
-0.36
-2.92
3.30
1.06
3.68
2.50
4.25
PAT before Minority Interest
10.84
9.62
8.63
8.26
-0.36
-2.92
3.31
1.06
3.69
2.51
4.26
Minority Interest
-0.02
-0.02
-0.01
-0.02
0.00
0.00
-0.01
0.00
-0.01
-0.01
-0.01
PAT Margin
5.87%
5.09%
5.14%
5.05%
-0.40%
-3.06%
3.03%
1.00%
3.88%
3.51%
4.14%
PAT Growth
23.13%
11.37%
4.61%
-
-
-
211.32%
-71.20%
47.20%
-41.18%
 
EPS
9.44
8.35
7.50
7.17
-0.31
-2.54
2.87
0.92
3.20
2.17
3.70

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
71.57
62.15
48.19
32.54
32.80
35.73
32.51
31.37
27.64
25.14
Share Capital
11.49
11.49
9.81
8.50
8.50
8.50
8.50
8.50
8.50
8.50
Total Reserves
60.09
50.67
36.55
24.04
24.29
27.23
24.01
22.86
19.14
16.63
Non-Current Liabilities
35.24
19.77
24.21
19.26
21.83
22.58
17.60
17.65
22.81
26.62
Secured Loans
21.05
12.02
17.41
13.94
19.12
16.19
11.70
12.57
13.72
16.45
Unsecured Loans
0.00
0.00
0.00
0.03
0.03
5.39
5.00
4.51
8.59
9.18
Long Term Provisions
0.61
0.51
0.47
0.26
0.27
0.29
0.23
0.38
0.00
0.14
Current Liabilities
81.83
63.04
80.98
54.37
52.46
36.29
37.19
36.45
28.90
31.02
Trade Payables
22.18
14.76
22.08
6.23
10.86
7.26
7.68
7.67
3.09
9.27
Other Current Liabilities
16.36
14.43
15.56
11.65
13.45
13.31
14.47
13.12
11.27
8.06
Short Term Borrowings
43.21
33.27
42.70
36.43
28.11
15.69
15.03
15.65
13.05
12.09
Short Term Provisions
0.07
0.58
0.64
0.06
0.03
0.04
0.02
0.01
1.50
1.59
Total Liabilities
188.76
145.07
153.47
106.25
107.16
94.68
87.37
85.53
79.40
82.83
Net Block
89.48
76.81
71.95
59.66
57.68
51.06
43.70
47.32
37.85
36.10
Gross Block
126.62
108.00
97.25
79.40
72.73
61.65
50.47
51.07
58.88
54.55
Accumulated Depreciation
37.14
31.20
25.30
19.73
15.05
10.59
6.77
3.75
21.03
18.45
Non Current Assets
113.33
84.01
78.70
67.02
61.55
57.79
50.91
54.66
48.84
44.85
Capital Work in Progress
20.61
2.33
3.34
4.91
2.91
0.14
0.00
0.00
2.44
0.95
Non Current Investment
0.16
0.16
0.22
0.22
0.22
0.21
0.23
0.34
0.91
0.86
Long Term Loans & Adv.
3.08
4.71
3.14
2.18
0.73
6.37
6.98
7.00
7.64
6.94
Other Non Current Assets
0.00
0.00
0.05
0.04
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
71.81
57.32
71.03
39.24
45.61
36.90
36.46
30.87
30.57
37.96
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
29.93
21.69
19.93
10.79
11.15
8.47
7.67
7.94
6.63
7.03
Sundry Debtors
32.56
27.89
38.08
16.71
23.08
19.18
18.66
18.66
19.42
23.50
Cash & Bank
1.88
2.78
5.78
1.27
1.30
0.60
1.61
1.13
0.38
2.36
Other Current Assets
7.45
0.00
0.00
3.91
10.08
8.64
8.52
3.14
4.14
5.07
Short Term Loans & Adv.
7.45
4.96
7.24
6.57
6.13
4.73
4.51
3.14
4.14
5.07
Net Current Assets
-10.02
-5.72
-9.95
-15.13
-6.84
0.61
-0.73
-5.58
1.66
6.95
Total Assets
185.14
141.33
149.73
106.26
107.16
94.69
87.37
85.53
79.41
82.82

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
15.88
20.91
8.55
6.31
8.75
8.72
12.88
16.05
3.49
-0.25
PBT
12.05
12.28
12.26
-0.08
-1.97
4.62
3.02
4.71
3.48
5.44
Adjustment
11.86
11.58
11.05
10.23
8.97
7.70
9.60
8.78
3.04
3.00
Changes in Working Capital
-5.40
-0.09
-14.53
-3.08
2.81
-2.21
0.91
3.91
-1.90
-6.63
Cash after chg. in Working capital
18.52
23.77
8.78
7.07
9.82
10.12
13.53
17.40
4.62
1.81
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-2.64
-2.86
-0.24
-0.76
-1.07
-1.40
-0.65
-1.35
-1.13
-2.06
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-31.52
-9.92
-16.50
-6.56
-13.33
-11.15
-5.18
-10.22
-6.18
-3.79
Net Fixed Assets
-0.12
-0.06
0.00
0.00
0.00
0.00
6.02
9.34
0.32
-0.09
Net Investments
0.00
0.04
0.00
0.00
0.00
-0.05
0.11
0.58
0.00
0.00
Others
-31.40
-9.90
-16.50
-6.56
-13.33
-11.10
-11.31
-20.14
-6.50
-3.70
Cash from Financing Activity
14.82
-14.07
12.13
0.05
5.03
1.42
-7.18
-5.45
0.72
5.50
Net Cash Inflow / Outflow
-0.82
-3.08
4.18
-0.21
0.44
-1.01
0.53
0.38
-1.97
1.45
Opening Cash & Equivalents
1.28
4.36
0.18
0.39
-0.05
0.96
0.43
0.05
2.36
0.91
Closing Cash & Equivalent
0.46
1.28
4.36
0.18
0.39
-0.05
0.96
0.43
0.38
2.36

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
62.32
54.11
47.24
38.26
38.56
42.01
38.23
36.88
32.50
29.55
ROA
5.77%
5.78%
6.36%
-0.34%
-2.89%
3.63%
1.22%
4.48%
3.09%
5.12%
ROE
14.39%
15.91%
20.93%
-1.11%
-8.51%
9.69%
3.31%
12.51%
9.50%
18.50%
ROCE
13.61%
15.20%
17.34%
5.83%
3.27%
11.59%
10.49%
13.73%
11.47%
16.35%
Fixed Asset Turnover
1.61
1.63
1.85
1.18
1.42
1.94
2.08
1.72
1.26
1.95
Receivable days
58.46
71.83
61.33
80.64
80.93
63.50
64.56
73.29
109.98
85.55
Inventory Days
49.92
45.31
34.39
44.46
37.57
27.08
27.01
28.05
35.01
40.41
Payable days
65.58
75.70
57.63
74.68
73.02
28.47
30.58
24.08
38.03
64.80
Cash Conversion Cycle
42.80
41.44
38.08
50.42
45.48
62.11
60.99
77.26
106.96
61.17
Total Debt/Equity
0.99
0.82
1.41
1.71
1.54
1.17
1.13
1.26
1.51
1.63
Interest Cover
3.25
3.48
3.34
0.98
0.57
2.19
1.70
1.96
1.81
2.24

Top Investors:

News Update:


  • Parnax Lab - Quarterly Results
    10th Feb 2025, 17:04 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.